Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Marimed (MRMD) Interest Expenses (2016 - 2025)

Marimed (MRMD) has disclosed Interest Expenses for 12 consecutive years, with $2.2 million as the latest value for Q4 2025.

  • Quarterly Interest Expenses rose 14.16% to $2.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $7.5 million through Dec 2025, up 8.04% year-over-year, with the annual reading at $7.5 million for FY2025, 8.04% up from the prior year.
  • Interest Expenses for Q4 2025 was $2.2 million at Marimed, up from $1.8 million in the prior quarter.
  • The five-year high for Interest Expenses was $2.6 million in Q2 2023, with the low at $200000.0 in Q1 2021.
  • Average Interest Expenses over 5 years is $1.3 million, with a median of $1.7 million recorded in 2024.
  • The sharpest move saw Interest Expenses plummeted 92.57% in 2021, then surged 700.32% in 2023.
  • Over 5 years, Interest Expenses stood at $279000.0 in 2021, then surged by 51.25% to $422000.0 in 2022, then soared by 269.19% to $1.6 million in 2023, then increased by 21.05% to $1.9 million in 2024, then rose by 14.16% to $2.2 million in 2025.
  • According to Business Quant data, Interest Expenses over the past three periods came in at $2.2 million, $1.8 million, and $1.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.